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Expression of HIV-1 Vpr causes cell cycle G2 arrest, changes in cell shape, and cell death over a large evolutionary
distance ranging from human to yeast cells. As a step toward understanding these highly conserved Vpr functions, we have
examined the effect of Vpr on cytoskeletal elements and the viability of fission yeast. We demonstrate that the changes in
cell morphology induced by Vpr in fission yeast are caused by several underlying cellular abnormalities, including increased
biosynthesis of chitin in the cell wall, disruption of the actin cytoskeleton, and altered polarity for cell growth. The extent of
these cellular alterations and cell survival correlates with the level of vpr expression. Accompanying cell death, Vpr induces
aberrant nuclear morphologies in fission yeast which are similar to those found during the apoptosis induced by Vpr in
mammalian cells. The Vpr-induced cytopathic effects and cell death can be suppressed by treatment with pentoxifylline, a
compound that inhibits HIV-1 viral replication and suppresses Vpr-induced cell cycle G2 arrest in human and fission yeast
cells. The results presented here suggest that pentoxifylline suppresses the effects of Vpr by blocking interactions of Vpr with
cellular proteins. Given that pentoxifylline has potential therapeutic value in blocking the effects of Vpr in HIV-infected
patients, understanding the molecular mechanisms by which pentoxifylline antagonizes Vpr may have general implications
for HIV therapy. © 1998 Academic Press
INTRODUCTION
Depletion of CD41 T cells is a hallmark of HIV-1
infection and disease progression. In vitro, viruses that
contain an intact vpr gene are unable to establish a
chronic infection of T-cells, because expression of vpr
will result in cell death (Rogel et al., 1995). However,
whether the death of T-cells by Vpr is due to the effects
of direct cell killing, apoptosis, or immune-mediated cell
death is not clear. Similarly, the role of Vpr in pathogen-
esis is not well understood, but infection with vpr defec-
tive or vpr-vpx (Tristem et al., 1992; Sharp et al., 1996)
defective simian immunodeficiency virus (SIV) amelio-
rates or abrogates disease, respectively (Gibbs et al.,
1995; Hoch et al., 1995; Lang et al., 1993), suggesting an
important role for Vpr function in viral pathogenesis.
HIV-1 Vpr is a 15-kDa virion-associated protein. Vpr
activates viral replication (Levy et al., 1994, 1995) and
promotes viral nuclear transport (Heinzinger et al., 1994).
Vpr also induces changes of cell morphology which
mimic cell differentiation (Levy et al., 1993), and it pre-
vents cell proliferation by arresting cells in the G2 phase
of the cell cycle in transfected human cells (He et al.,
1995; Jowett et al., 1995; Re et al., 1995; Rogel et al.,
1995). Vpr also induces G2 arrest and changes of cell
morphology in the fission yeast Schizosaccharomyces
pombe similar to its effects on human cells; this conser-
vation of function provides the opportunity to study Vpr in
this simple eukaryotic organism (Zhang et al., 1997; Zhao
et al., 1996).
Given that Vpr affects morphology of human and bud-
ding and fission yeast cells (Levy et al., 1993; Macreadie
et al., 1995; Zhang et al., 1997; Zhao et al., 1996), it is an
interesting question as to how Vpr affects cell morphol-
ogy. This paper examines the effect of Vpr on fission
yeast cytoskeletal elements to determine if alterations of
these elements underlie the changes in cell morphology.
The well-characterized normal behavior of actin and
chitin deposition during the cell cycle of S. pombe (Ko-
bori et al., 1989; Mark and Hyams, 1985; Matsusaka et al.,
1995; Mitchison and Nurse, 1985) provides a basis for
these studies on the effect of Vpr. Prior to mitosis, actin
is localized at the growing tips of cells, and it is this
localization of actin which determines the orientation of
cell growth (growth polarity) in fission yeast. At the onset
of mitosis, actin relocalizes to an equatorial ring where
septum formation will occur. Chitin is deposited uni-
formly into growing cell wall, and large amounts are
deposited into the developing septum.
In this study, we show that Vpr expression disrupts the
1 To whom correspondence and reprint requests should be ad-
dressed at 2430 N. Halsted Street, No. 218, Chicago, Illinois 60614. Fax:
(773) 880-6609. E-mail: yzhao@nwu.edu.
VIROLOGY 246, 266–276 (1998)
ARTICLE NO. VY989208
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
266
normal patterns of actin localization and chitin deposi-
tion, resulting in the loss of cell growth polarity. Vpr
appears to affect multiple components of the basic cel-
lular functions, and these multifaceted effects of Vpr
combine to lead to the polymorphic abnormal cellular
morphology. Furthermore, these morphological abnor-
malities are associated with cell death, and Vpr induces
in yeast a process of cell death in which the nuclear
changes are similar to those occurring during apoptosis
in mammalian cells. This induction of cell death in hu-
man and fission yeast cells is another conserved activity
of Vpr. We also found that pentoxifylline antagonizes the
cytopathic effects of Vpr in yeast and examined one
possible mechanism for this antagonistic effect.
RESULTS
Vpr-induced morphological changes occur at sites
of increased chitin biosynthesis
To examine Vpr-induced morphological changes in
individual cells, we used calcofluor staining and fluores-
cence microscopy to examine the deposition of chitin in
the cell wall when the vpr gene was either repressed or
induced. Under vpr-repressing conditions, cells show the
normal pattern of uniform calcofluor staining on growing
cell wall and intense staining of septa formation even
after 48 h incubation (Figs. 1A, left, and 1B, a). Irregular
and highly intensified intracellular staining was observed
in vpr-expressing cells (Fig. 1A, right). When individual
vpr-expressing cells were examined, deposition of chitin
in the cell wall (Fig. 1B, b–d, bottom) was found to
accumulate at the site of the irregular protruding struc-
ture (Fig. 1B, b–d, top) as early as 20 h after vpr induction
with intensification of the calcofluor staining up to 48 h.
A time-lapse series of an individual cell shows that an
abnormal deposit of chitin begins 16 h after vpr induction.
By 20 h, it has become a prominent deposit of chitin,
which is associated with a bulge in the cell surface (Fig.
1C). In some of the septa-containing cells, septa were
thickened, as indicated by broad, strong calcofluor stain-
ing (Fig. 1B, b).
Vpr alters cytoskeletal structure and growth
polarity of yeast cells
In vpr-repressed cells, normal growth and F-actin
staining patterns (Matsusaka et al., 1995; Mitchison and
Nurse, 1985) were found for the various stages of the cell
cycle. Phalloidin staining of actin patches at the tips of
the cells, an indication of apical growth, showed that
cells with monopolar (G1 phase) or bipolar (G2 phase)
growth were present (Fig. 2A, a–b). Furthermore, dividing
M phase cells were identified by actin staining of the
newly formed septum (Fig. 2A, c), and no actin patches
were seen immediately after cell division (Fig. 2A, d). In
contrast to these normal patterns of actin localization
when vpr was repressed (Fig. 2B, left), cells in which vpr
was induced from 24 to 48 h (Fig. 2B, right) do not have
any obvious actin patches at the tips of the cells, and
instead actin was dispersed throughout the cells. The
absence of actin patches at the tips of the cells indicates
that the normal growth polarity of the cell has been
disrupted. Additionally, bundle-like actin filaments were
clearly present in some of the vpr-expressed cells, but
these filaments were not observed in normal or vpr-
repressed cells.
Vpr-induced cell death and its correlation
to vpr expression
Colony-forming ability of vpr-expressing cells was
used as one measure of whether Vpr is lethal to yeast
cells. All of the cells were viable at the onset of vpr gene
induction, but rapid loss of colony-forming ability was
observed after vpr was induced. Only 7.75 6 1.00% of the
total cell population formed colonies 16 h after vpr in-
duction and only 0.15 6 0.02% formed colonies 24 h after
vpr gene induction. In parallel with the inhibition of col-
ony-forming ability, expression of vpr stopped the growth
of the culture as previously reported (Zhao et al., 1996).
The plating experiments and growth of the culture do not
distinguish between a cytostatic effect of Vpr where cell
growth ceases but cell death occurs slowly after an
extended period of arrest and active, rapid killing of the
yeast cell by Vpr. To determine whether Vpr rapidly in-
duces cell death, a fluorescent dye that measures both
intracellular metabolic activity and cell membrane integ-
rity (Kretschmar et al., 1996; Molecular Probes, Eugene,
OR) was used. Actively respiring cells were clearly de-
tected at the onset of the vpr-induction (Fig. 3A, left) and
in vpr-repressed cells (data not shown) by the formation
of orange–red fluorescent intravacuolar bodies. How-
ever, cells cultured for 24 h after vpr induction (Fig. 3A,
middle) have a diffuse green cytoplasmic fluorescence
indicative of live cells with little active metabolism. By
48 h after vpr induction (Fig. 3A, right), the cells have an
extremely bright, diffuse, green-yellowish fluorescence
indicative of dead cells.
To test whether Vpr-induced cellular death is depen-
dent on the level of expression, we inserted the HIV-1 vpr
gene into the vectors pREP41, with a lower level of
expression relative to pREP1N, and pREP81, with the
lowest level of expression (Basi et al., 1993). This set of
three expression vectors, pREP1N, pREP41, and pREP81,
have different sequences in the TATA box and conse-
quently express the same mRNA at different levels. The
relative expression levels of Vpr from these three vectors
were determined by immunoblot analyses. A 15-kDa pro-
tein band that reacts to the anti-Vpr serum was found in
each gene construct. Vpr levels correlate with the ex-
pression levels of these vectors as previously described
(Basi et al., 1993; Forsburg, 1993; Fig. 3B). In control
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FIG. 1. (A) Vpr increases chitin biosynthesis in the cell wall of S. pombe. Cells were stained with calcofluor under vpr-repressing conditions (left)
and 48 h after vpr induction (right). (B) Association of Vpr-induced protruding structures with cell wall chitin biosynthesis. (Top) S. pombe cells
visualized by light microscopy show cell morphology. (Bottom) S. pombe cells visualized by fluorescent microscopy to show chitin accumulation. a,
a dividing vpr-repressed cell showing normal morphology; b–d, vpr-expressed cells. Cells are normalized to a 10 mM scale. (C) A time-lapse series
of one cell starting at 16 h after vpr induction and continuing every h until 20 h. In addition to calcofluor staining, the cell was stained with Hoechst
33342, and at 16 h this DNA staining shows an abnormal ring-shaped nucleus (see Fig. 4 and Results).
FIG. 2. (A) Patterns of actin localization at different stages of the cell cycle under vpr-repressing conditions. a, mono-polar growth stage in G1; b,
bipolar growth stage in G2; c, cell division during M phase; and d, postcell division. Cells were stained with TRITC-labeled phalloidin and observed
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experiments with vpr expression repressed, no Vpr pro-
teins were detected in these constructs (data not
shown). Inhibition of colony-forming ability by Vpr was
also dependent on the expression level and was the
highest in pREP1N::vpr (Fig. 3C, green line). Inhibition of
colony-forming ability decreased in the intermediate ex-
pression construct pREP41::vpr, and no alteration of col-
ony-forming ability was observed with the low expres-
sion construct pREP81::vpr (Fig. 3C, black line).
Vpr affects nuclear morphology in a manner
reminiscent of apoptosis
We examined the potential effect of Vpr on nuclear
structure by staining with DAPI. The nuclear morphology
of vpr-repressed cells (Figs. 4A, left, and 4B, a) is normal,
with the centrally placed nucleus showing a typical,
brightly staining hemisphere of chromatin and a less
intensely staining nucleolus (Toda, 1981). In contrast,
after 24 h of vpr expression cells showed aberrant DAPI-
staining patterns, including an apparent loosing and pos-
sibly fragmentation of chromatin and ring-like structures
(Figs. 4A, right, and 4B, b–d). Similar ring-like nuclei with
fragmented chromatin were also observed when
Hoechst 3342 was used to stain the nucleus in living
cells (Fig. 1C). Since these aberrant nuclear structures
are reminiscent of apoptosis in mammalian cells, we
tested whether these abnormal structures indicate DNA
fragmentation, a further sign of apoptosis. S. pombe
chromosomes were visualized by pulse phase or in-
versed phase gel electrophoresis. No DNA fragmenta-
tion was observed (data not shown) in the size range of
1 to 9 Mb by the pulse-phase gels (Smith et al., 1987) or
in the size range of 50 to 200 kb by the inversed phase
gel analyses (Turmel and Lalande, 1988) as is seen in the
early stages of apoptosis in mammalian cells (Walker et
al., 1993). In addition, another assay of DNA fragmenta-
tion by terminal transferase labeling (Bromidge et al.,
1995; Li et al., 1995) showed no sign of DNA fragmenta-
tion (data not shown).
Pentoxifylline alleviated Vpr-induced cytopathic
effects and cell death in a dose-dependent manner
Recent studies indicate that pentoxifylline can block
HIV-1 Vpr-induced cell cycle G2 arrest in both human
cells (Poon et al., 1997) and fission yeast cells (Y. Zhao,
unpublished data). To test whether pentoxifylline could
inhibit Vpr-induced cytopathic effects, vpr-induced and
vpr-repressed cells were treated with 5 mM pentoxifyl-
line and compared to cells without treatment 24 h after
vpr induction. As expected, the vpr-repressed cells with
or without pentoxifylline were morphologically normal
(Figs. 5A, a–b, and 5B, a–b), and the vpr-induced cells
showed increased chitin biosynthesis in the cell wall and
morphological changes (Figs. 5B, c, and 5A, c). However,
no cell morphological changes or increased chitin bio-
synthesis were observed in vpr-induced cells treated
with pentoxifylline (Figs. 5A, d, and 5B, d), indicating that
pentoxifylline can prevent these effects of Vpr.
Colony-forming ability after 18 h of vpr induction was
also evaluated for pentoxifylline concentrations ranging
from 0.01 to 5 mM. Below 3 mM no effect was seen on
cell survival, but from 3 to 5 mM a dose-dependent
amelioration of Vpr-induced cell death was observed.
Approximately 14.3 6 4.7% of the cells treated with 3 mM,
23.3 6 2.7% with 4 mM and 79.0 6 10.1% with 5 mM of
the pentoxifylline formed colonies while only 0.5 6 0.03%
of the cells formed colonies without pentoxifylline treat-
ment (Fig. 6A). However, with longer times of vpr expres-
sion pentoxifylline treatment was unable to prevent cell
death, and most of the cells failed to form colonies 24 h
(3–4 mM) or 48 h (5 mM) after vpr induction (data not
shown).
One possibility is that pentoxifylline might antagonize
Vpr effects by reducing expression of vpr. To test this
possibility, vpr mRNA and protein were measured in cells
treated with pentoxifylline by Northern and immunoblot
analyses, respectively. The vpr mRNA was not detected
in vpr-repressing cells (Fig. 6B, bottom), whereas vpr
mRNA was detected in all cells with or without pentoxi-
fylline treatment after 18 h of vpr induction (Fig. 6B, top).
In the vpr-induced cells, no significant change in mRNA
levels (in reference to leu2 mRNA levels, see Materials
and Methods for details) was observed at lower concen-
trations of pentoxifylline, but slight increases in vpr
mRNA occurred at higher concentrations of pentoxifyl-
line (1.2 6 0.3 fold for 3 mM, 2.9 6 1.5 fold for 4 mM, and
7.1 6 3.0 fold for 5 mM; the standard errors are for
triplicate experiments). Immunoblot analyses with anti-
Vpr antibody showed that the 15-kDa Vpr band was not
seen in vpr-repressed cells (Fig. 6C, bottom). In vpr-
induced cells, the 15-kDa band had a similar strong
density regardless of whether the cells were treated with
pentoxifylline (Fig. 6C, top). Thus, pentoxifylline does not
under fluorescent microscopy. (B) Alteration of cell growth polarity and actin localization 48 h after vpr induction (right) compared to vpr-repressed
cells (left).
FIG. 3. Correlation of Vpr-induced cell death with vpr gene expression. (A) Cell viability measured by the yeast live/dead assay at 0 (left), 24 (middle),
and 48 (right) h after vpr induction. (B) (Top) An immunoblot to show levels of Vpr produced in pREP1N::vpr (left), pREP41::vpr (middle), and pREP81::vpr
(right). (Bottom) An irrelevant protein to show the relative amount of total proteins added in each lane. (C) Inhibition of colony-forming ability is
proportional to the level of vpr expression. Green line, high level of vpr expression (pREP1N::vpr); Red line, intermediate level (pREP41::vpr); black line,
low level (pREP81::vpr).
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antagonize the effects of Vpr by decreasing the amount
of Vpr in the cell.
DISCUSSION
Expression of the HIV-1 vpr gene in fission yeast cells
induces arrest in G2 phase of the cell cycle and causes
unique changes in cell morphology (Zhao et al., 1996). It
is noteworthy in this genetically well-characterized yeast
that no known single mutation causes the combination of
abnormalities seen with Vpr although some single mu-
tations give a subset of the abnormalities (see below). In
particular, none of the known S. pombe mutations caus-
FIG. 4. Nuclear morphology of S. pombe cells. (A) Cells were stained with DAPI under vpr-repressing (left) or vpr-expressing (right) conditions. (B)
Vpr-induced aberrant nuclear morphologies. a, normal; b–d, ring-like and fragmented nuclei.
FIG. 5. Suppression of Vpr-induced morphological changes and chitin accumulation by pentoxifylline treatment. Cells were collected at 24 h after
thiamine was removed from growth medium. (A) Cell morphology observed by light microscopy. (B) Chitin biosynthesis was visualized by fluorescent
microscopy. (Left) Control cells not treated with pentoxifylline. (Right) Cells treated with 5 mM pentoxifylline. (Top) vpr-repressed cells. (Bottom)
vpr-expressed cells.
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ing G2 arrest induce the morphological abnormalities
seen with Vpr. These observations suggest that Vpr does
not function simply by inactivating a single yeast protein
but more likely functions by interacting with multiple
target proteins in S. pombe. This possibility is supported
by the number of proteins which associate with Vpr
(Bouhamdan et al., 1996; Chen et al., 1997; Refaeli et al.,
1995; Wang et al., 1995), although none of these Vpr-
interacting proteins are currently known to be involved in
Vpr-induced G2 arrest or cytopathic effects.
Here we show that these Vpr-induced morphologi-
cal changes can be attributed to a change of cell
growth polarity, disruption of cytoskeletal structures,
and increased chitin biosynthesis in the cell wall,
which further illustrates the complexities of Vpr action
in S. pombe. The loss of cytoskeletal integrity and cell
growth polarity was indicated by disassociation of the
F-actin patches from the active growing tips of the
cells (Fig. 2B, right). This regulation of actin localiza-
tion is a fundamental process in the control of cell
morphology and growth polarity (Matsusaka et al.,
1995). The fact that F-actin was dispersed throughout
the cells and aggregated in some cells as bundle-like
structures (Fig. 2B, right) suggests a possible disrup-
tion of actin’s anchorage to the cell membrane, an
attachment necessary for maintaining the integrity of
the cytoskeleton (Mulholland et al., 1994). Vpr has also
disrupted the actin cytoskeleton in the budding yeast
S. cerevisiae (Gu et al., 1997). It has been proposed
that Vpr has these effects on actin by virtue of its
sequence similarity to a protein which interacts with
actin (Macreadie et al., 1995). Vpr resembles (32%
identify, 45% similarity of the entire sequence) this
budding yeast protein, Sac1p, which is known to be
involved in assembly of the actin cytoskeleton (Cleves
et al., 1989; Macreadie et al., 1995; Whitters et al.,
1993). We were not able to access the role of Sac1p in
Vpr-induced changes of actin cytoskeleton as the
functional homologue of Sac1p has not yet been iden-
tified in fission yeast.
Other evidence for a disruption of the cytoskeleton
comes from the correlation of localized chitin accumu-
lation with the irregular protruding structures of the
cells (Fig. 1B, b–d). The reason why Vpr induces in-
creased cell wall chitin biosynthesis at sites of mor-
phological abnormalities is unclear. This unusual phe-
notype is particularly interesting as it has not been
described preciously in any of the S. pombe mutants.
Formation of multiple septa without an obvious in-
crease in nuclear ploidy that is seen in some cells
(Figs. 1A, right, and 1B, b) suggests a possible sepa-
ration of nuclear division and cytokinesis. A similar
phenotype showing multiple septa was found in
S. pombe cells with a mutant protein kinase ssp1
gene, and the ssp1 gene product is also required for
alteration of growth polarity and actin localization in
fission yeast (Matsusaka et al., 1995). Experiments are
in progress to test whether the ssp1 mutation can
suppress Vpr-induced morphological changes.
These profound structural alterations caused by Vpr
are associated with cell death, and only 8% of the total
cell population formed colonies 16 h after vpr-induction.
A fluorescent dye assay for metabolic activity indicated
that cells had little metabolic activity 24 h after vpr in-
duction and were metabolically inert by 48 h (Fig. 3A).
Given that the maximum level of mRNA is found 16 h after
induction of the nmt1 promoter (our unpublished data,
Maundrell, 1990), these results indicate that the process
of cell death begins a few hours after maximum induction
of vpr. Furthermore, the Vpr-induced cell death was de-
pendent on the expression level of the vpr gene with a
positive correlation between the level of vpr gene ex-
FIG. 6. Dose-dependent suppression of Vpr-induced cell death by
pentoxifylline. (A) Dose-dependent survival at 18 h after vpr induction.
(B) Northern blot analyses of vpr-repressed (bottom) vs vpr-expressed
(top) cells that are treated with 0 to 5 mM pentoxifylline. (C) Immunoblot
analyses of vpr-repressed (bottom) vs vpr-expressed (top) cells that are
treated with 0 to 5 mM pentoxifylline. 1T, with thiamine; 2T, without
thiamine.
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pression and the extent of Vpr-induced cell death (Figs.
3B and 3C).
In vitro studies in mammalian cells indicate that trans-
fection of a HIV-1 construct containing a wild-type vpr
gene into human cells eventually kills the entire culture
of infected cells (Rogel et al., 1995). Expression of the
HIV-1 vpr gene alone from an autonomously replicating
plasmid demonstrated a similar effect (He et al., 1995;
Levy et al., 1993). These cells, however, typically remain
viable in culture for at least 1–2 weeks before death
(Levy et al., 1993; Rogel et al., 1995), possibly due to the
cytostatic effect of Vpr arresting cells in G2 (Rogel et al.,
1995). The observation that normal T-cells in the quies-
cent Go stage can remain viable for a much longer
period of time, however, suggests that the cytostatic
effect is not the only cause of cell death. In fact, the
severe cytopathic effects caused by Vpr strongly suggest
that Vpr directly induces cell death. The discrepancy
between the acute cell death induced by Vpr in S. pombe
cells and the delayed cell death in human cells could be
due to differences in expression levels of Vpr. Indeed,
HeLa cells, when transfected with a wild-type vpr gene
that is expressed from the strong CMV promoter, died
rapidly within 2–3 days (J. Jowett, personal communica-
tion; our unpublished data).
In the process of killing the yeast cell, Vpr induces
nuclear abnormalities similar to the nuclear changes
observed in early stages of apoptosis in mammalian
cells (Figs. 1C and 4; Wyllie, 1981). This suggestion of an
apoptotic-like process in yeast is particularly interesting
because while apoptosis has been extensively studied in
multicellular eukaryotic organisms as simple as the
nematode Caenorhabditis elegans with only 1090 cells
(Fraser and Evan, 1996), a process similar to apoptosis
has not been demonstrated until recently in unicellular
eukaryotic organisms. However, our attempts to detect
the DNA fragmentation usually seen during apoptosis in
mammalian cells (Walker et al., 1993) by conventional
means (i.e., DNA laddering, terminal transferase assay
by flow cytometry analysis) failed to find evidence of
DNA fragmentation induced by Vpr in yeast (data not
shown). Although Vpr does not induce DNA fragmenta-
tion in yeast, DNA fragmentation does not always occur
during mammalian apoptosis (Cohen et al., 1992; Ober-
hammer et al., 1993). Vpr does induce apoptosis in hu-
man cells (Stewart et al., 1997), and the nuclear changes
in human cells are similar to the changes seen in fission
yeast (Fig. 4). This similar effect on nuclear morphologies
raises the possibility that these results with Vpr reveal in
yeast the existence of an evolutionary precursor to apo-
ptosis. This possibility is considerably strengthened by
two recent reports (Ink et al., 1997; Jurgensmeier et al.,
1997) that the Bax and Bak proteins, which induce apop-
tosis in mammalian cells, induce a process with similar-
ities to apoptosis in S. pombe. The fact that three mam-
malian apoptosis-inducing proteins kill S. pombe
strongly support the idea that an apoptotic-like process
occurs in S. pombe.
We found in this study that pentoxifylline in the range
of 3 to 5 mM abrogates Vpr-induced cytopathicity and
cell death in a dose-dependent manner (Fig. 6A). Pen-
toxifylline in a similar concentration range (0.5 to 1.0 mM)
has an antagonistic effect on the G2 arrest induced by
Vpr in human cells (Poon et al., 1997). We have shown
that pentoxifylline can also alleviate the G2 arrest in-
duced by Vpr in S. pombe cells (Y. Zhao et al., unpub-
lished data). While it seems likely that the mechanism by
which pentoxifylline antagonizes the effects of Vpr is the
same in human and S. pombe cells, the molecular mech-
anism of the antagonism by pentoxifylline is at present
unknown. The original rationale for testing pentoxifylline
on Vpr-induced G2 arrest comes from the use of pentoxi-
fylline in cancer chemotherapy. The DNA damage from
chemotherapy causes cells to arrest in G2; this DNA
damage check point allows cells to repair their DNA
prior to mitosis. Pentoxifylline prevents the G2 arrest
induced by DNA damage, and this premature mitosis
with unrepaired DNA increases chromosomal aberra-
tions resulting in cell lethality (Fringert et al., 1986;
Ohsaki et al., 1996; Traganos et al., 1991). While the
prevention of G2 arrest is not understood in molecular
terms, pentoxifylline is thought to act by blocking the
signal generated by damaged DNA which leads to arrest
in G2 (O’Connor et al., 1993). As pentoxifylline can also
alleviate the G2 arrest induced by Vpr in human (Poon et
al., 1997) and S. pombe cells (Y. Zhao et al., unpublished
data), Vpr could act either by damaging DNA or by
sending a signal similar to that sent by damaged DNA to
give G2 arrest. It seems unlikely that Vpr causes DNA
damage. First, the analogy to DNA damage indicates that
pentoxifylline would enhance cell killing when it prevents
G2 arrest by Vpr. In contrast, however, we found that
pentoxifylline treatment of S. pombe cells decreased
Vpr-induced cell death (Fig. 6A). Second, expression of
vpr in human cells does not increase the mutation rate
as expected for DNA damage but decreases it when
measured in a cell-free system (Mansky, 1996). Since Vpr
is unlikely to cause DNA damage, the antagonism by
pentoxifylline suggests that Vpr might mimic the signal
sent by DNA damage which ultimately causes G2 arrest;
a target for Vpr action may therefore include some part of
the signal transduction pathway for the DNA damage
checkpoint. Recent findings that Vpr directly interacts
with two excision DNA repair enzymes, uracil DNA
glycosylase and HHR23, is additional support for the
idea that Vpr interacts with this signaling pathway
(Bouhamdan et al., 1996; Chen et al., 1997).
Pentoxifylline is also known as an inhibitor of TNF-a,
which activates viral expression from the HIV long ter-
minal repeat (LTR) (Biswas et al., 1994; Dezube et al.,
1993). Vpr itself activates the LTR under specific condi-
tions (Wang et al., 1995) and pentoxifylline could conceiv-
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ably inhibit this activation as well. However, these effects
of pentoxifylline on expression from the HIV LTR are
unrelated to the antagonism of pentoxifylline reported
here because vpr was expressed from a heterologous
yeast promoter rather than the HIV LTR. In these studies
using this yeast promoter, measurements of vpr mRNA
and protein did not show a significant decrease with
pentoxifylline treatment (Figs. 6B and 6C). Thus, pentoxi-
fylline is not antagonizing the effects of Vpr in yeast by
reducing the amount of Vpr. It is also noteworthy that
pentoxifylline antagonizes several effects of Vpr includ-
ing not only G2 arrest but also cell lethality and morpho-
logical abnormalities. Given that Vpr has a pleiotropic
effect in yeast and that a relatively high concentration of
pentoxifylline is required to antagonize these effects,
these observations imply that Vpr could be the direct
target of pentoxifylline.
In summary, we have demonstrated that HIV-1 Vpr
expression in fission yeast cells disrupts a number of
cellular functions including alterations of cell growth
polarity, cell wall biosynthesis, and cytoskeletal struc-
tures. The combined effect of these Vpr-induced subcel-
lular changes could lead to the unique polymorphic ap-
pearance observed in the fission yeast cells. Further-
more, we found that the cytopathic effects imposed by
Vpr result in cell death. The aberrant nuclear morphology
accompanying cell death suggests that there may be a
process similar to apoptosis in fission yeast. Vpr-induced
cytopathic effects and cell death are ameliorated by
treatment with pentoxifylline. The antagonism of pentoxi-
fylline on the effects of Vpr in both fission yeast and
human cells suggests that pentoxifylline interacts with
highly conserved cellular components. Therefore, pen-
toxifylline or its analog may have potential therapeutic
value in blocking the cytopathic effect of HIV Vpr in
HIV-infected patients. Fission yeast can serve as a
model system for understanding both the mechanism of
Vpr action and the mechanism of antagonism by pentoxi-
fylline as a basis for developing more potent derivatives
of pentoxifylline.
MATERIALS AND METHODS
Yeast strain and media
The wild-type S. pombe SP223 (h2ade-216 leu1-32
ura4-294) cells containing pREP::vpr constructs were
maintained in standard Edinburgh minimal medium
(EMM) supplemented with uracil and adenine at 75
mg/ml (Fantes, 1977). Thiamine (20 mM) was added to
the medium at a final concentration of 20 mM to re-
press vpr gene expression controlled by nmt1 (no
message in thiamine) promoter. The HIV-1 vpr gene
was induced approximately 200-fold by growth on me-
dium without thiamine as described previously (Fors-
burg, 1993; Maundrell, 1990; Maundrell, 1993; Zhao et
al., 1996). All liquid cultures were grown at 30°C with
constant shaking at 200 rpm. Agar plates were incu-
bated at 30°C for 3–4 days to obtain individual colo-
nies. As a control to ensure that the observed effects
were specific for vpr, the green fluorescent protein
(GFP) gene or the vector alone without an insert were
expressed in a manner similar to that of REP1N; no
cell death or morphological changes were seen when
a strain of either of these plasmids was grown in
medium without thiamine (data not shown).
Molecular cloning of the HIV-1 vpr gene
into S. pombe expression vectors
Insertion of the HIV-1 vpr gene from the pNL4-3 viral
strain into the yeast expression vector pREP1N and its
expression in the wild-type S. pombe strain SP223
were described previously (Zhao et al., 1996). A similar
strategy was also used to clone HIV-1 vpr gene into
pREP41 and pREP81, derivatives of pREP1N (Basi et
al., 1993). Briefly, the 340-bp vpr gene fragment was
amplified by PCR, resolved by electrophoresis on a 1%
agarose gel, excised, and purified using Gene-Clean
beads (Bio 101, Vista, CA). The DNA fragment was then
digested with BamHI and NdeI enzymes and inserted
into vectors pREP41 and PREP81. These new con-
structs were designated pREP41::vpr and pREP81::vpr,
respectively. Fusion of the vpr gene ATG start codon
with the nmt1 promoter carried on pREP vectors was
confirmed by DNA sequencing using an internal
primer, VPR-int2 (59-CCAAGTATCCCCGTAAGT-39). The
new constructs were transformed into the wild-type
SP223 cells as described previously (Broker, 1987;
Zhao and Lu, 1996). The procedure of immunoblot
analyses used to determine the relative vpr expression
levels from these three gene constructs has been
described previously (Zhao et al., 1996).
Cell growth and colony-forming units
S. pombe cells containing the pREP::vpr constructs
were first grown to stationary phase in the presence of
20 mM thiamine. Cells were then washed three times
with distilled water, diluted to a final concentration of
approximately 2 3 105 cells/ml in 20 ml of selection EMM
with or without thiamine, and grown at 30°C with shaking
(200 rpm). An aliquot of each culture was collected at
sequential time intervals (0, 16, 24, 48, and 64 h), the
number of cells per milliliter were counted using a he-
macytometer, and cells were plated onto thiamine-con-
taining EMM plates. Colony-forming units (CFU) were
calculated from the number of colonies that grew on the
plates as a percentage of the number of cells originally
plated corrected by the plating efficiency of vpr-re-
pressed cells. The plating efficiency of vpr-repressed
cells was determined for each time point from the thia-
mine-containing culture by plating on thiamine-contain-
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ing EMM plates and ranged from 100 to 40% over the
various time points.
Yeast viability assay
S. pombe cell viability was determined with a commer-
cial LIVE/DEAD yeast viability kit (Molecular Probes, Eu-
gene, OR) following the manufacturer’s instructions. Via-
ble yeast cells that are metabolically active and have an
intact plasma membrane convert the fluorescent sub-
strate FUN-1 from a diffuse green fluorescent color to a
compact orange–red fluorescent metabolite within cells.
Briefly, the wild-type SP223 cells were prepared as de-
scribed. Cells collected at 0, 24, and 48 h after vpr
induction were resuspended into GH solution (2% D-(1)-
glucose, 10 mM Na-HEPES, pH 7.2). FUN-1 solution was
prepared by diluting 10 mM stock FUN-1 solution in GH
solution to a final concentration of 6.3–50 mM. A 100-ml
aliquot of FUN-1 solution was added to an equal volume
of yeast suspension. A 10-ml aliquot of the yeast suspen-
sion was then trapped between a slide and coverslip and
sealed with wax. Cells were examined by fluorescent
microscopy using Omega fluorescein/tetramethylrho-
damine filter sets. Actively respiring cells are marked
clearly with orange–red fluorescent structures, while
dead cells exhibit extremely bright, diffuse, green–yellow
fluorescence. Cells with intact membranes but with little
or no metabolic activity stain with diffuse green cytoplas-
mic fluorescence but lack orange–red intravacuolar
bodies.
Fluorescent characterization of subcellular structures
Calcofluor (Sigma F6259), a chitin-specific dye, was
used as a fluorescent cell wall marker to examine the
growth pattern of S. pombe cells. Fluorochrome tetram-
ethylrhodamine (TRITC)-labeled phalloidin (Sigma,
P1951) was used as a F-actin-specific probe to deter-
mine the distribution of F-actin and cytoskeletal struc-
tures within the S. pombe cells. Nuclear organization of
the S. pombe cells was examined by DAPI (49, 6-
diamidino-2-phenylindole, Sigma, D9542) staining. The
procedures for cell preparation and staining using cal-
cofluor, phalloidin, and DAPI have been described pre-
viously (Alfa et al., 1993). The procedures for the time-
lapse photography were basically as described
(Chikashige et al., 1994).
Apoptosis assays
A terminal transferase (TdT)-based commercial kit
(Boehringer Mannheim, Catalog No. 1686795) that is
designed to detect and quantitate apoptosis at the sin-
gle-cell level by flow cytometry analyses of fluorescein-
labeled DNA strand breaks was used according to the
manufacturer’s instructions. DNA fragmentation was
also examined by pulsed-field gel electrophoresis (Bio-
Rad CHEF Mapper XA) and by inversed-field gel electro-
phoresis (Hoefer Scientific Instruments) using proce-
dures described previously (Smith et al., 1987; Turmel
and Lalande, 1988).
Pentoxifylline treatment and Vpr expression analyses
Pentoxifylline [1-(59-oxohexyl)-3,7-dimethylxanthine,
Sigma P1784], dissolved in distilled water as a stock
solution (20 mM), was diluted to the experimental con-
centrations in EMM. Both Northern and immunoblot
analyses were performed following standard procedures
described previously (Alfa et al., 1993). The levels of vpr
mRNA were quantitated using phosphorimage analyses
(Storm Model 860, Molecular Dynamics Inc., Sunnyvale,
CA) in reference to the mRNA levels of the leu2 gene.
Leu2 was on the same plasmid with vpr but expressed
from a different promoter. The average levels of mRNA
with standard errors under each treatment were ob-
tained from three independent experiments.
ACKNOWLEDGMENTS
This work was supported in part by grants from Chicago Pediatric
Faculty Foundation and National Institutes of Health 1R29-AI-40891-01
(Y.Z.). The authors thank Steve Wolinsky, Mitsuhiro Yanagida, and An-
drew Shenker for critical reviews of this manuscript, Ram Yogev for
support and encouragement, Maurice R. G. O’Gorman for assistance
on forward light scatter analyses, and Jeremy B. M. Jowett and Irwin
S. Y. Chen for sharing unpublished data. The HIV-1 BH10 Vpr antiserum
was obtained through the AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH (Wang et al., 1995).
REFERENCES
Alfa, C., Fantes, P., Hyams, J., McLeod, M., and Warbrick, E. (1993).
Nutritional control of entry into stationary phase determined by flow
fluorocytometry. In ‘‘Experiments with Fission Yeast: A Laboratory
Course Manual’’, pp. 52–56. Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY.
Basi, G., Schmid, E., and Maundrell, K. (1993). TATA box mutations in the
Schizosaccharomyces pombe nmt1 promoter affect transcription ef-
ficiency but not the transcription start point or thiamine repressibility.
Gene 123, 131–136.
Biswas, D. K., Ahlers, C. M., Dezube, B. J., and Pardee, A. B. (1994).
Pentoxifylline and other protein kinase C inhibitors down-regulate
HIV-LTR NF-kappa B induced gene expression. Mol. Med. 1, 31–43.
Bouhamdan, M., Benichou, S., Rey, F., Navarro, J. M., Agostini, I., Spire,
B., Camonis, J., Slupphaug, G., Vigne, R., Benarous, R., and Sire, J.
(1996). Human immunodeficiency virus type 1 Vpr protein binds to the
uracil DNA glycosylase DNA repair enzyme. J. Virol. 70, 697–704.
Broker, M. (1987). Transformation of intact Schizosaccharomyces
pombe cells with plasmid DNA. BioTechniques 5, 516.
Bromidge, T. J., Howe, D. J., Johnson, S. A., and Phillips, M. J. (1995).
Adaptation of the TdT assay for semi-quantitative flow cytometric
detection of DNA strand breaks. Cytometry 20, 257–260.
Chen, I. S. Y., Withers-Ward, E., Jowett, J. B. M., Stewart, S. A., Chow, S.,
and Sawutz, D. (1997). New opportunities for HIV therapy from dis-
covery to clinical proof-of-concept. In ‘‘Second Joint Conference of
the Strategic Program for Innovative Research on AIDS Treatment
(SPIRAT) and the National Cooperative Drug Discovery Groups for
the Treatment of HIV Infection (NCDDG-HIV),’’ Vienna, Virginia.
Chikashige, Y., Ding, D. Q., Funabiki, H., Haraguchi, T., Mashiko, S.,
Yanagida, M., and Hiraoka, Y. (1994). Telomere-led premeiotic chro-
mosome movement in fission yeast. Science 264, 270–273.
274 ZHAO ET AL.
Cleves, A. E., Novick, P. J., and Bankaitis, V. A. (1989). Mutations in the
Sac1 gene suppress defects in yeast Golgi and yeast actin function.
J. Cell Biol. 109, 2939–2950.
Cohen, G. M., Sun, X. M., Snowden, R. T., Dinsdale, D., and Skilleter,
D. N. (1992). Key morphological features of apoptosis may occur in
the absence of internucleosomal DNA fragmentation. Biochem. J.
286(2), 331–334.
Dezube, B. J., Pardee, A. B., Chapman, B., Beckett, L. A., Korvick, J. A.,
Novick, W. J., Chiurco, J., Kasdan, P., Ahlers, C. M., and Ecto, L. T.
(1993). Pentoxifylline decreases tumor necrosis factor expression
and serum triglycerides in people with AIDS. J. AIDS 6, 787–794.
Fantes, P. (1977). Control of cell size and cycle time in Schizosaccha-
romyces pombe. J. Cell Sci. 24, 51–67.
Forsburg, S. L. (1993). Comparison of Schizosaccharomyces pombe
expression systems. Nucleic Acids Res. 21, 2955–2956.
Fraser, A., and Evan, G. (1996). A license to kill. Cell 85, 781–784.
Fringert, H. J., Chang, J. D., and Pardee, A. B. (1986). Cytotoxic, cell
cycle, and chromosomal effects of methylxanthines in human tumor
cells treated with alkylating agents. Cancer Res. 46, 2463–2467.
Gibbs, J. S., Lackner, A. A., Lang, S. M., Simon, M. A., Sehgal, P. K.,
Daniel, M. D., and Desrosiers, R. C. (1995). Progression to AIDS in the
absence of a gene for vpr or vpx. J. Virol. 69, 2378–2383.
Gu, J., Emerman, M., and Sandmeyer, S. (1997). Small heat shock
protein suppression of Vpr-induced cytoskeletal defects in budding
yeast. Mol. Cell. Biol. 17, 4033–4042.
He, J., Choe, S., Walker, R., Di Marzio, P., D., Morgan, D. O., and Landau,
N. R. (1995). Human immunodeficiency virus type 1 viral protein R
(Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting
p34cdc2 activity. J. Virol. 69, 6705–6711.
Heinzinger, N., Bukinsky, M., Haggerty, S., Ragland, A., Kewalramani, V.,
Lee, M., Gendelman, H., Ratner, L., Stevenson, M., and Emerman, M.
(1994). The Vpr protein of human immunodeficiency virus type 1
influences nuclear localization of viral nucleic acids in nondividing
host cells. Proc. Natl. Acad. Sci. USA 91, 7311–7315.
Hoch, J., Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C.,
Dittmer, U., Hunsmann, G., Fuchs, D., Mu¨ller, J., Sopper, S., Flecken-
stein, B., and U¨berla, K. T. (1995). vpr deletion mutant of simian
immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69,
4807–4813.
Ink, B., Zornig, M., Baum, B., Hajibagheri, N., James, K., Chittenden, T.,
and Evan, G. (1997). Human Bak induces cell death in Schizosac-
charomyces pombe with morphological changes similar to those
with apoptosis in mammalian cells. Mol. Cell. Biol. 17, 2468–2474.
Jowett, J. B., Planelles, V., Poon, B., Shah, N. P., Chen, M., and Chen,
I. S. Y. (1995). The human immunodeficiency virus type 1 vpr gene
arrests infected T cells in the G2 1 M phase of the cell cycle. J. Virol.
69, 6304–6313.
Jurgensmeier, J. M., Krajewski, S., Armstrong, R. C., Wilson, G. M.,
Oltersdorf, T., Fritz, L. C., Reed, J. C., and Ottilie, S. (1997). Bax- and
Bak-induced cell death in the fission yeast Schizosaccharomyces
pombe. Mol. Biol. Cell 8, 325–339.
Kobori, H., Yamada, N., Taki, A., and Osumi, M. (1989). Actin is associ-
ated with the formation of the cell wall in reverting protoplast of the
fission yeast Schizosaccharomyces pombe. J. Cell Biol. 94, 635–646.
Kretschmar, M., Nichterlein, T., Nebe, C. T., Hof, H., and Burger, K. J.
(1996). Fungicidal effect of tyrothricin on Candida albicans. Mycoses
39, 45–50.
Lang, S., Weeger, M. M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G.,
Juller, J., Juller- Hermelink, H., Fuchs, D., Wachter, H., Daniel, M. M.,
Destosiers, R. C., and Fleckenstein, B. (1993). Importance of vpr for
infection of rhesus monkeys with simian immunodeficiency virus.
J. Virol. 67, 902–912.
Levy, D. N., Fernandes, L. S., Williams, W. V., and Weiner, D. B. (1993).
Induction of cell differentiation by human immunodeficiency virus 1
vpr. Cell 72, 541–550.
Levy, D. N., Refaeli, Y., MacGregor, R. R., and Weiner, D. B. (1994). Serum
Vpr regulates productive infection and latency of human immunode-
ficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 10873–10877.
Levy, D. N., Refaeli, Y., and Weiner, D. B. (1995). Extracellular Vpr protein
increases cellular permissiveness to human immunodeficiency virus
replication and reactivates virus from latency. J. Virol. 69, 1243–1252.
Li, X., James, W. M., Traganos, F., and Darzynkiewcz, Z. (1995). Application
of biotin, digoxigenin or fluorescein conjugated deoxynucleotides to
label DNA strand breaks for analysis of cell proliferation and apoptosis
using flow cytometry. Biotechnic Histochem. 70, 234–242.
Macreadie, I. G., Castelli, L. A., Hewish, D. R., Kirkpatrick, A., Ward,
A. C., and Azad, A. A. (1995). A domain of human immunodeficiency
virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs
causes cell growth arrest and structural defects. Proc. Natl. Acad.
Sci. USA 92, 2770–4.
Mansky, L. M. (1996). The mutation rate of human immunodeficiency
virus type 1 is influenced by the vpr gene. Virology 222, 391–400.
Mark, J., and Hyams, J. S. (1985). Localization of F-actin through the cell
division cycle of Schizosaccharomyces pombe. Eur. J. Cell Biol. 39,
27–32.
Matsusaka, M., Hirata, D., Yanagida, M., and Toda, T. (1995). A novel
protein kinase gene ssp11 is required for alteration of growth polar-
ity and actin localization in fission yeast. EMBO J. 14, 3325–3338.
Maundrell, K. (1990). nmt1 of fission yeast. J. Biol. Chem. 265, 10857–
10864.
Maundrell, K. (1993). Thiamine-repressible expression vectors pREP
and pRIP for fission yeast. Gene 123, 127–130.
Mitchison, J. M., and Nurse, P. (1985). Growth in cell length in the fission
yeast Schizosaccharomyces pombe. J. Cell Sci. 75, 357–376.
Mulholland, J., Preuss, D., Moon, A., Wong, A., Drubin, D., and Botstein,
D. (1994). Ultrastructure of the yeast actin cytoskeleton and its as-
sociation with the plasma membrance. J. Cell Biol. 125, 381–391.
Oberhammer, F., Fritsch, G., Schmied, M., Pavelka, M., Printz, D., Pur-
chio, T., Lassmann, H., and Schulte-Hermann, R. (1993). Condensa-
tion of the chromatin at the membrance of an apoptotic nucleus is
not associated with activation of an endonuclease. J. Cell Sci. 104,
317–326.
O’Connor, P. M., Ferris, D. K., Pagano, M., Draetta, G., Pines, J., Hunter,
T., Longo, D. L., and Kohn, K. W. (1993). G2 delay induced by nitrogen
mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-
kinase complex. J. Biol. Chem. 268, 8298–8308.
Ohsaki, Y., Ishida, S., Fujikane, T., and Kikuchi, K. (1996). Pentoxifylline
potentiates the antitumor effect of cisplatin and etoposide on human
lung cancer cell lines. Oncology 53, 327–333.
Poon, B., Jowett, J. B., Stewart, S. A., Armstrong, R. W., Rishton, G. M.,
and Chen, I. S. (1997). Human immunodeficiency virus type 1 vpr
gene induces phenotypic effects similar to those of the DNA alky-
lating agent, nitrogen mustard. J. Virol. 71, 3961–3971.
Re, F., Braaten, D., Franke, E. K., and Luban, J. (1995). Human immuno-
deficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting
the activation of p34cdc2-cyclin B. J. Virol. 69, 6859–6864.
Refaeli, Y., Levy, D. N., and Weiner, D. B. (1995). The glucocorticoid
receptor type II complex is a target of the HIV-1 vpr gene product.
Proc. Natl. Acad. Sci. USA 92, 3621–3625.
Rogel, M. E., Wu, L. I., and Emerman, M. (1995). The human immuno-
deficiency virus type 1 vpr gene prevents cell proliferation during
chronic infection. J. Virol. 69, 882–888.
Sharp, P. M., Bailes, E., Stevenson, M., Emerman, M., and Hahn, B. H.
(1996). Gene acquisition in HIV and SIV. Nature 383, 586–587
Smith, C. L., Matsumoto, T., Niwa, O., Klco, S., Fan, J., Yanagida, M., and
Cantor, C. R. (1987). Electrophoretic karyotype for Schizosaccharo-
myces pombe by pulse field gel electrophoresis. Nucleic Acids Res.
15, 4481–4489.
Stewart, S. A., Poon, B., Jowett, J. B., and Chen, I. S. (1997). Human
immunodeficiency virus type 1 Vpr induces apoptosis following cell
cycle arrest. J. Virol. 71, 5579–5592.
Toda, T., Yamamoto, M., and Yanagida, M. (1981). Sequential alter-
ations in the nuclear chromatin region during mitosis of the
275HIV-1 Vpr INDUCED CYTOPATHIC EFFECTS AND CELL DEATH
fission yeast Schizosaccharomyces pombe: Video fluorescence
microscopy of synchronously growing wild type and cold-sensi-
tive cdc mutants by using a DNA-binding fluorescent probe. J. Cell
Sci. 52, 271–287.
Traganos, F., Kapuscinski, J., and Darzynkiewicz, Z. (1991). Caffeine
modulates the effects of DNA-intercalating drugs in vitro: A flow
cytometric and spectrophotometric analysis of caffeine interaction
with novantrone, doxorubicin, ellipticine, and the doxorubicin ana-
logue AD198. Cancer Res. 51, 3682–3689.
Tristem, M., Marshall, C., Karpas, A., and Hill, F. (1992). Evolution of
the primate lentiviruses: evidence from vpx and vpr. EMBO J. 11,
3405–12.
Turmel, C., and Lalande, M. (1988). Resolution of Schizosaccharomyces
pombe chromosomes by field inversion gel electrophoresis. Nucleic
Acids Res. 16, 4727.
Walker, P. R., Kokileva, L., LeBlanc, J., and Sikorska, M. (1993). Detection
of the initial stages of DNA fragmentation in apoptosis. BioTech-
niques 15, 1032–1040.
Wang, L., Mukherjee, S., Jia, F., Narayan, O., and Zhao, L. (1995).
Interaction of virion protein Vpr of human immunodeficiency virus
type 1 with cellular transcription factor Sp1 and transactivation of
viral long terminal repeat. J. Biol. Chem. 270, 25564–25569.
Whitters, E. A., Cleves, A. E., McGee, T. P., Skinner, H. B., and Bankaitis,
V. A. (1993). Sac1p is an integral membrance protein that influences
the cellular requirement for phospholipid transfer protein function
and inositol in yeast. J. Cell Biol. 122, 79–94.
Wyllie, A. H. (1981). Cell death: A new classification separating apopto-
sis from necrosis. In ‘‘Cell Death in Biology and Pathology’’ (I. D.
Bowen and R. A. Lockshin, Eds.), pp. 9–34. Chapman & Hall, New
York.
Zhang, C., Rasmussen, C., and Chang, L.-J. (1997). Cell cycle inhibitory
effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces
pombe. Virology 230, 103–112.
Zhao, Y., Cao, J., O’Gorman, M. R. G., Yu, M., and Yogev, R. (1996). Effect
of human immunodeficiency virus Type 1 protein R (vpr) gene ex-
pression on basic cellular functions of fission yeast Schizosaccha-
romyces pombe. J. Virol. 70, 5821–5826.
Zhao, Y., and Lu, Y. (1996). Lithium-acetate based protocol for yeast
transformation. In ‘‘Practical Protocols in Molecular Biology’’ (Y. M. Li
and Y. Zhao, Eds.), pp. 63–64. Science Press, New York.
276 ZHAO ET AL.
